Omicron News and Research

RSS

US mortality rates far higher than peer nations, leading to millions of "Missing Americans"

A new study found that more than one million US deaths a year - including many young and working-age adults - could be avoided if the US had mortality rates similar to its peer nations.

17 Jul 2023

Omicron subvariant BA.5 can cause more severe disease

Omicron-derived virus variants are currently responsible for most SARS-CoV-2 infections worldwide. Compared to earlier virus variants, Omicron rarely causes severe disease.

17 Jul 2023

Unveiling long COVID: new study explores symptoms and strain variations

Researchers investigated the variation in the clinical and demographic characteristics of acute SARS-CoV-2.

17 Jul 2023

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Researchers examined the immune response and potential cross-protection in hospitalized patients with breakthrough infections.

17 Jul 2023

Study: Empathetic people more likely to support the international sharing of coronavirus vaccines

People with more empathy and cosmopolitan beliefs are more likely to support the international sharing of coronavirus vaccines, a new study shows.

14 Jul 2023

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Researchers identified the anti-SARS-CoV-2 function of phospholipid scramblase 1 (PLSCR1).

14 Jul 2023

Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

Researchers tested the efficacy of a two to three-dose intranasal (IN) regimen of the NDV-HXP-S vaccine.

14 Jul 2023

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

Researchers developed a mAb-based blocking enzyme-linked immunosorbent assay (bELISA) to detect SARS-CoV-2 in animals.

11 Jul 2023

Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV

7DW8-5, a glycolipid that utilizes the body's non-specific immune response to quickly combat viral infections, including COVID-19 in vivo.

11 Jul 2023

Alarming pediatric hospital admissions linked to COVID-19 in England

Most SARS-CoV-2 associated hospital admissions in children and adolescents in England were due to SARS-CoV-2 or SARS-CoV-2 was a contributory factor. These results should inform future public health initiatives and research.

9 Jul 2023

Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

Researchers assessed acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC).

6 Jul 2023

Moderna COVID-19 vaccine effective in children five and under

mRNA-1273 vaccine (Moderna) shows strong effectiveness in reducing symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. Further research is needed to explore long-term effectiveness and the potential need for booster doses.

5 Jul 2023

Beyond the lungs: SARS-CoV-2's multi-organ impact revealed

Researchers present the mechanisms by which SARS-CoV-2 could infect the brain and affect memory.

5 Jul 2023

SYS6006 investigational COVID-19 mRNA vaccine shows promise as fourth dose booster

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide.

4 Jul 2023

Wastewater surveillance highlights significant underestimation of COVID-19 cases in Canada

Research examines the correlation between SARS-CoV-2 levels in untreated water and COVID-19 cases and hospitalizations in Ontario, Canada. It also highlights the value of wastewater data in enhancing local decision-making and COVID-19 surveillance systems.

3 Jul 2023

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

Researchers used antibody testing to predict the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

3 Jul 2023

Omicron News and Research

US mortality rates far higher than peer nations, leading to millions of "Missing Americans"

Omicron subvariant BA.5 can cause more severe disease

Unveiling long COVID: new study explores symptoms and strain variations

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Study: Empathetic people more likely to support the international sharing of coronavirus vaccines

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV

Alarming pediatric hospital admissions linked to COVID-19 in England

Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

Moderna COVID-19 vaccine effective in children five and under

Beyond the lungs: SARS-CoV-2's multi-organ impact revealed

SYS6006 investigational COVID-19 mRNA vaccine shows promise as fourth dose booster

Wastewater surveillance highlights significant underestimation of COVID-19 cases in Canada

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

New COVID-19 mRNA vaccine is safe and highly immunogenic as a heterologous booster: Study

Study suggests blood group A may directly influence SARS-CoV-2 infectious risk

Understanding the biological effects of SARS-CoV-2 persistence in children

Study finds link between blood type and COVID-19 susceptibility

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News